A
AcadiFi
QD
QuantFinance_Dev2026-03-30
cfaLevel IFinancial Reporting & Analysis

Why does IFRS capitalize development costs while US GAAP expenses almost everything?

I'm confused about the treatment of R&D under IFRS vs. US GAAP. A practice problem shows a biotech company capitalizing $4 million of development costs under IFRS but expensing all $4 million under GAAP. This seems like a massive difference. What are the rules?

138 upvotes
AcadiFi TeamVerified Expert
AcadiFi Certified Professional

The treatment of research and development costs is one of the most significant differences between IFRS and US GAAP in financial reporting.

IFRS (IAS 38) -- Two-Phase Approach

  1. Research phase -- All costs are expensed as incurred. Research is original investigation aimed at gaining new knowledge without a specific commercial application yet.
  1. Development phase -- Costs MUST be capitalized as an intangible asset if ALL six criteria are met:
  • Technical feasibility of completing the asset
  • Intention to complete and use/sell it
  • Ability to use or sell the asset
  • Probable future economic benefits (market or internal use exists)
  • Adequate technical and financial resources to complete
  • Ability to reliably measure costs

US GAAP (ASC 730) -- Expense Almost Everything

Both research and development costs are expensed as incurred. The only exception is software development costs (ASC 985-20): costs incurred after technological feasibility is established may be capitalized.

Example: Nextera Biotech spends $12 million on a new drug compound:

  • Phase 1 (Research): $5M on basic compound discovery -- expensed under both frameworks.
  • Phase 2 (Development): $3M on clinical trials after feasibility established -- capitalized under IFRS, expensed under GAAP.
  • Phase 3 (Development): $4M on regulatory preparation and production setup -- capitalized under IFRS, expensed under GAAP.
Loading diagram...

Financial Statement Effects:

MetricIFRS (capitalize $7M)US GAAP (expense all)
Current-year expense$5M$12M
Intangible asset on BS$7M$0
Net income (Year 1)Higher by $7M pre-taxLower
Future amortization$7M amortized over useful lifeNone

Analyst Adjustments

When comparing Nextera (IFRS) to a US GAAP competitor, an analyst should:

  1. Add back capitalized development costs to the IFRS company's expenses for comparability.
  2. Reverse the intangible asset from the balance sheet.
  3. Adjust ratios like R&D intensity (R&D expense / revenue) accordingly.

Exam Tip: The six criteria for IFRS capitalization are heavily tested. A common trap is that meeting only five of six means the costs must still be expensed. Also, once a cost is expensed in the research phase under IFRS, it cannot be retroactively capitalized.

Explore more IFRS vs. GAAP differences in our CFA Level I FRA course.

📊

Master Level I with our CFA Course

107 lessons · 200+ hours· Expert instruction

#research-development#ias-38#capitalization#intangible-assets